-
AOD9604 5mg $50.00 (USD)Add to cart
AOD9604 is a derivative of human growth hormone (hGH) and a modified version of the hGH fragment 176-191 peptide, incorporating a di-sulfide bridge. What’s exciting about this peptide is that it does not affect IGF-1 or insulin levels and is, therefore, not a risk in promoting glucose intolerance.
-
Melanotan 2 $50.00 (USD)Select options
Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of the endogenous alpha-melanocyte-stimulating hormone (α-MSH).
In research settings, it is widely utilized to investigate the melanocortin system’s role in regulating skin pigmentation (melanogenesis), sexual behavior, and energy homeostasis (appetite suppression) through non-selective activation of melanocortin receptors.
Note: This product is intended for research use only and is not for human consumption. -
Cagrisema 10mgAdd to cart-21%LimitedOriginal price was: $150.00 (USD).$119.00 (USD)Current price is: $119.00 (USD).
Cagrisema is a potent new blend, a combination that integrates two peptides – cagrilintide and semaglutide.
Semaglutide is a GLP-1 receptor agonist; a version of human GLP-1 hormone, modified to resist the degradation by the enzyme dipeptidyl peptidase-4.
Cagrilintdide, on the other hand, is an amylin analogue. Its role is to mimic the human hormone amylin and is structurally designed to be resistant to enzymatic degradation.
Together, these two peptides profoundly influence chemical structures and induce hormonal changes:
- Leading to the receptor changes within the pancreas and the brain
- Boosting insulin secretion
- Interacting with the receptors involved in appetite regulation
- Mimicking the action of amylin
- Decreasing glucagon secretion
All in all, this is a sophisticated, more importantly, incredibly potent combination of two peptides whose actions complement each other. Cagrisema combination influences some key hormonal processes and plays a role in metabolic regulation.
-
Cagrilintide $230.00 (USD)Select options
Buy Cagrilintide Online
Cagrilintide is a long-acting amylin analogue, currently at the forefront of peptide research due to its rather interesting potential beneficial effect in individuals with diabetes. But what’s so special about amylin? Well, amylin is another peptide hormone, co-secreted with insulin, which inhibits food intake, delays gastric emptying, and, most importantly, reduces blood glucose levels.
Back to cagrilintide… it was originally developed to improve on the initial amylin analogue called pramlintide. The problem with pramlintide is its short half-life and undesired side effects.
Cagrilintide was (and still is being) developed to alter the half-life, potency and stability of pramlintide, and other amylin analogues.Since, it’s still a relatively new peptide, it still needs to undergo further research so we can make sure its as effective and safe.
